Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Macrocyclic complexes of alpha-emitting radionuclides and their use in targeted radiotherapy of cancer

Macrocyclic complexes of alpha-emitting radionuclides and their use in targeted radiotherapy of cancer

US Patent 11554182 · Granted Jan 17, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Macrocyclic complexes of alpha-emitting radionuclides and their use in targeted 2025
Macrocyclic complexes of alpha-emitting radionuclides and their use in targeted 2025
Rear tractor screen assembly2024
Macrocyclic complexes of alpha-emitting radionuclides and their use in targeted 2024
Macrocyclic complexes of alpha-emitting radionuclides and their use in targeted 2024
Rhenium complexes and methods of use for treating cancer2024
Metal-chelating compositions and their use in methods of removing or inhibiting 2023
Metal-chelating compositions and their use in methods of removing or inhibiting 2023
Display screen or portion thereof with graphical user interface2022
Display screen or portion thereof with graphical user interface2022
Macrocyclic complexes of alpha-emitting radionuclides and their use in targeted 2022
Macrocyclic complexes of alpha-emitting radionuclides and their use in targeted 2022